Preclinical Imaging In-VIVO Systems And Reagents Market By Modality Analysis; By Reagents Analysis and By Regional Analysis – Global Forecast by 2023 - 2028
The preclinical imaging in vivo systems and reagents Market is expected to be around US$ 1350 million by 2028 and will grow at a CAGR of more than 6% in the given forecast period.
COVID-19 Impact Analysis Report
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
6
REPORT DESCRIPTION
Preclinical imaging is the visualization of residing animals for studies purposes, which include drug development. Imaging modalities have long been critical to the researcher in observing modifications, both at the organ, tissue, mobile, or molecular level, in animals responding to physiological or environmental modifications. Imaging modalities which are non-invasive and In-VIVO have turn out to be particularly critical to take a look at animal fashions longitudinally. These imaging systems may be labeled into commonly morphological/anatomical and commonly molecular imaging techniques. Strategies along with high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are normally used for anatomical imaging. Whilst optical imaging (fluorescence and bioluminescence), positron emission tomography (puppy), and single photon emission computed tomography (SPECT) are typically used for molecular visualizations
How Big is the Global Preclinical Imaging In-VIVO Systems And Reagents Market?
The preclinical imaging in vivo systems and reagents Market is expected to be around US$ 1350 million by 2028 and will grow at a CAGR of more than 6% in the given forecast period.
The major driving factors of Global Preclinical Imaging IN-VIVO Systems and Reagents Market are as follows:
• Technical advancements in the area of molecular imaging
• Growing market demand for noninvasive small animal imaging techniques
• Increasing number of public and private initiative and financial support to support preclinical researches
The restraining factors of Global Preclinical Imaging In-VIVO Systems and Reagents Market are as follows:
• Strict rules leading preclinical research
• Major installation and operational cost related with preclinical
The Global Preclinical Imaging In-VIVO Systems and Reagents Market is segmented on the lines of its modality, reagents and regional. Based on modality segmentation it covers optical imaging systems, standalone fluorescence imaging systems, bioluminescence/fluorescence imaging systems, optical + X-Ray/optical + CT, micro-PET systems, preclinical nuclear imaging systems, micro-MRI systems, trimodality (SPECT/PET/CT) systems, micro-SPECT systems Micro-CT systems, micro-ultrasound systems, preclinical magnetic particle imaging (MPI) systems and preclinical photo acoustic imaging systems. Under reagents segmentation it covers preclinical optical imaging reagents, fluorescent imaging reagents, bioluminescent imaging reagents, preclinical nuclear imaging reagents, preclinical SPECT probes, preclinical MRI contrast agents, preclinical PET tracers, gadolinium-based preclinical MRI contrast agents, manganese-based preclinical MRI contrast agents, iron-based preclinical MRI contrast agents, preclinical CT contrast agents, barium-based preclinical CT contrast agents, preclinical ultrasound contrast agents, gold nano particles, iodine-based preclinical CT contrast agents and gastrografin-based preclinical CT contrast agents. The Global Preclinical Imaging In-VIVO Systems and Reagents market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Preclinical Imaging In-VIVO Systems and Reagents Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Preclinical Imaging in Vivo Systems and Reagents Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Global Preclinical Imaging In-VIVO Systems and Reagents Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Aspect Imaging Ltd, Bruker Corporation, Fujifilm Holdings Corporation, Li-Cor Biosciences, MR Solutions Ltd., Mediso Ltd., Milabs B.V., MiltenyiBiotec GmbH, Perkinelmer and Trifoil Imaging. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Preclinical Imaging In-VIVO Systems and Reagents Market has been segmented as below:
By Modality Analysis
• Optical Imaging Systems
• Standalone Fluorescence Imaging Systems
• Bioluminescence/Fluorescence Imaging Systems
• Optical + X-Ray/Optical + CT
• Micro-PET Systems
• Preclinical Nuclear Imaging Systems
• Micro-MRI Systems
• Trimodality (SPECT/PET/CT) Systems
• Micro-SPECT Systems Micro-CT Systems
• Micro-Ultrasound Systems
• Preclinical Magnetic Particle Imaging (MPI) Systems
• Preclinical Photo acoustic Imaging Systems
By Reagents Analysis
• Preclinical Optical Imaging Reagents
• Fluorescent Imaging Reagents
• Bioluminescent Imaging Reagents
• Preclinical Nuclear Imaging Reagents
• Preclinical SPECT Probes
• Preclinical MRI Contrast Agents
• Preclinical PET Tracers
• Gadolinium-based Preclinical MRI Contrast Agents
• Manganese-based Preclinical MRI Contrast Agents
• Iron-based Preclinical MRI Contrast Agents
• Preclinical CT Contrast Agents
• Barium-based Preclinical CT Contrast Agents
• Preclinical Ultrasound Contrast Agents
• Gold Nano particles
• Iodine-based Preclinical CT Contrast Agents
• Gastrografin-based Preclinical CT Contrast Agents
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Preclinical Imaging In-VIVO Systems and Reagents Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Preclinical Imaging In-VIVO Systems and Reagents Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Dialysis Disposable Devices Market
Digital Breast Tomosynthesis market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.2 Preclinical Imaging Market Size Estimation
2.2.1.1 Bottom-Up Approach
2.2.1.2 Top-Down Approach
2.3 Preclinical Imaging Market Breakdown and Data Triangulation
2.4 Research Assumptions & Limitations
2.4.1 Assumptions
3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion
4 Premium Insights
4.1 Global Preclinical Imaging Market Overview
4.2 Preclinical Imaging Products Market Share, By Region (2019)
4.3 Global Preclinical Imaging Systems Market, By Modality (2019–2025)
4.4 Global Preclinical Imaging Reagents Market, By Type (2019–2025)
4.5 Preclinical Imaging Market, By Region (2019 vs 2025)
5 Preclinical Imaging Market Overview
5.1 Introduction
5.2 Preclinical Imaging Market Dynamics
5.2.1 Key Market Drivers
5.2.1.1 Technological Advancements in the Field of Molecular Imaging
5.2.1.2 Increasing Market Demand for Noninvasive Small-Animal Imaging Techniques
5.2.1.3 Growing Number of Public-Private Initiatives and Funding to Support Preclinical Researches
5.2.2 Key Market Restraints
5.2.2.1 Strict Regulations Governing Preclinical Research
5.2.2.2 Significant Installation and Operational Costs Associated With Preclinical Imaging Modalities
5.2.3 Key Market Opportunity
5.2.3.1 Emerging Markets to Offer New Growth Opportunities
5.2.4 Key Market Challenge
5.2.4.1 Technological and Procedural Limitations Associated With Standalone Preclinical Imaging Systems
6 Industry Insights
6.1 Introduction
6.2 Value Chain Analysis
6.3 Supply Chain Analysis
6.3.1 Key Stakeholders
6.3.2 Key Influencers
6.4 Industry Trends
6.4.1 Ongoing Development of Hybrid and Multi-Modality Preclinical Imaging Systems
6.5 Porter’s Five Forces Analysis
6.5.1 Threat of New Entrants
6.5.2 Threat of Substitutes
6.5.3 Bargaining Power of Suppliers
6.5.4 Bargaining Power of Buyers
6.5.5 Intensity of Competitive Rivalry
7 Global Preclinical Imaging Market, By Modality
7.1 Introduction
7.2 Optical Imaging Systems
7.2.1 Bioluminescence/Fluorescence Imaging Systems
7.2.2 Standalone Fluorescence Imaging Systems
7.2.3 (Optical + X-Ray)/(Optical + CT) Systems
7.3 Nuclear Imaging Systems
7.3.1 Micro-PET Systems
7.3.1.1 Standalone PET Systems
7.3.1.2 PET/CT Systems
7.3.1.3 PET/MRI Systems
7.3.2 Micro-Spect Systems
7.3.2.1 Standalone Spect Systems
7.3.2.2 Spect/CT Systems
7.3.2.3 Spect/MRI Systems
7.3.3 Trimodality (Spect/PET/CT) Systems
7.4 Micro-MRI
7.5 Micro-Ultrasound
7.6 Micro-CT
7.7 Photoacoustic Imaging Systems
7.8 Magnetic Particle Imaging (MPI) Systems
8 Global Preclinical Imaging Market, By Reagent
8.1 Introduction
8.2 Preclinical Optical Imaging Reagents
8.2.1 Bioluminescent Imaging Reagents
8.2.1.1 Luciferins
8.2.1.2 Proluciferins
8.2.1.3 Coelenterazine
8.2.1.4 Other Bioluminescent Imaging Reagents
8.2.2 Fluorescent Imaging Reagents
8.2.2.1 Green Fluorescent Proteins
8.2.2.2 Red Fluorescent Proteins
8.2.2.3 Infrared Dyes
8.2.2.4 Other Fluorescent Imaging Reagents
8.3 Preclinical Nuclear Imaging Reagents
8.3.1 Preclinical PET Tracers
8.3.1.1 Fluorine-18-Based Preclinical PET Tracers
8.3.1.2 Carbon-11-Based Preclinical PET Tracers
8.3.1.3 Copper-64-Based Preclinical PET Tracers
8.3.1.4 Other PET Tracers
8.3.2 Preclinical Spect Probes
8.3.2.1 Technetium-99m-Based Preclinical Spect Probes
8.3.2.2 Iodine-131-Based Preclinical Spect Probes
8.3.2.3 Gallium-67-Based Preclinical Spect Probes
8.3.2.4 Thallium-201-Based Preclinical Spect Probes
8.3.2.5 Other Spect Probes
8.4 Preclinical MRI Contrast Agents
8.4.1 Gadolinium-Based Preclinical Contrast Agents
8.4.2 Iron-Based Preclinical Contrast Agents
8.4.3 Manganese-Based Preclinical Contrast Agents
8.5 Preclinical Ultrasound Contrast Agents
8.6 Preclinical CT Contrast Agents
8.6.1 Iodine-Based Preclinical CT Contrast Agents
8.6.2 Barium-Based Preclinical CT Contrast Agents
8.6.3 Gold Nanoparticles
8.6.4 Gastrografin-Based Preclinical CT Contrast Agents
9 Preclinical Imaging Market, By Region
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia-Pacific
9.5 Rest of the World (RoW)
10 Competitive Landscape
10.1 Overview
10.2 Preclinical Imaging Market Share Analysis, By Key Player, 2015
10.3 Competitive Scenario
10.3.1 New Product Launches
10.3.2 Agreements, Partnerships, and Collaborations
10.3.3 Geographical Expansions
10.3.4 Acquisitions
The Global Preclinical Imaging In-VIVO Systems and Reagents Market has been segmented as below:
By Modality Analysis
• Optical Imaging Systems
• Standalone Fluorescence Imaging Systems
• Bioluminescence/Fluorescence Imaging Systems
• Optical + X-Ray/Optical + CT
• Micro-PET Systems
• Preclinical Nuclear Imaging Systems
• Micro-MRI Systems
• Trimodality (SPECT/PET/CT) Systems
• Micro-SPECT Systems Micro-CT Systems
• Micro-Ultrasound Systems
• Preclinical Magnetic Particle Imaging (MPI) Systems
• Preclinical Photo acoustic Imaging Systems
By Reagents Analysis
• Preclinical Optical Imaging Reagents
• Fluorescent Imaging Reagents
• Bioluminescent Imaging Reagents
• Preclinical Nuclear Imaging Reagents
• Preclinical SPECT Probes
• Preclinical MRI Contrast Agents
• Preclinical PET Tracers
• Gadolinium-based Preclinical MRI Contrast Agents
• Manganese-based Preclinical MRI Contrast Agents
• Iron-based Preclinical MRI Contrast Agents
• Preclinical CT Contrast Agents
• Barium-based Preclinical CT Contrast Agents
• Preclinical Ultrasound Contrast Agents
• Gold Nano particles
• Iodine-based Preclinical CT Contrast Agents
• Gastrografin-based Preclinical CT Contrast Agents
By Regional Analysis
• North America
• Europe
• Asia-Pacific
• Rest of the World
Got a question? We've got answers. If you have some other questions, see our support center.
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE